# Study of IBR733 Cell Injection in Acute Myeloid Leukemia

> clinical trial · VERIFIED · 2026-07-02

Status: RECRUITING · Sponsor: Imbioray (Hangzhou) Biomedicine Co., Ltd. · Condition: Acute Myeloid Leukemia

- Company: Imbioray (Hangzhou) Biomedicine Co., Ltd.
- Sector: cell therapy
- Primary source: https://clinicaltrials.gov/study/NCT06234904

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.